Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
As constituents of lysosomes, lysosomal membrane proteins play important roles in lysosome-related autophagy and apoptosis. In a recent proteomic study of lysosomal proteins, we identified
transmembrane protein 192
(
TMEM192
) as a novel lysosomal membrane protein candidate. Using specific anti-
TMEM192
antibody and lysosomal markers, the lysosomal localization of
TMEM192
was determined by immunofluorescence.
TMEM192
shows a wide expression pattern in mouse tissues. Interestingly,
TMEM192
was found to be highly expressed in tumor cell lines, while it was not expressed or was detected at low levels in normal cell lines. By knockdown of
TMEM192
expression using specific siRNAs, we found that
TMEM192
-deficient HepG2
hepatoma
cells show growth inhibition and increased apoptosis. Autophagy was shown to be activated through detection of LC3II expression. Increased apoptosis was inhibited by blocking the expression of the key autophagy gene Atg7 in
TMEM192
-deficient HepG2 cells. The results suggest that
TMEM192
is important for tumor cell growth and proliferation.
TMEM192
deficiency can induce autophagy in tumor cells, and can further activate apoptosis by the mitochondrial pathway through autophagy.
TMEM192
promotion of autophagy may be a new route for tumor therapy.
...
PMID:Lysosomal membrane protein TMEM192 deficiency triggers crosstalk between autophagy and apoptosis in HepG2 hepatoma cells. 2273 46
The
Transmembrane protein 192
(
TMEM192
) is a lysosomal/late endosomal protein initially discovered by organellar proteomics.
TMEM192
exhibits four transmembrane segments with cytosolic N- and C-termini and forms homodimers. Devoid of significant homologies, the molecular function of
TMEM192
is currently unknown. Upon
TMEM192
knockdown in
hepatoma
cells, a dysregulation of autophagy and increased apoptosis were reported. Here, we aimed to define the physiological role of
TMEM192
by analysing consequences of
TMEM192
ablation in mice. Therefore, we compared the biochemical properties of murine
TMEM192
to those of the human orthologue. We reveal lysosomal residence of murine
TMEM192
and demonstrate ubiquitous tissue expression. In brain,
TMEM192
expression was pronounced in the hippocampus but also present in the cortex and cerebellum, as analysed based on a lacZ reporter allele. Murine
TMEM192
undergoes proteolytic processing in a tissue-specific manner. Thereby, a 17 kDa fragment is generated which was detected in most murine tissues except liver.
TMEM192
processing occurs after lysosomal targeting by pH-dependent lysosomal proteases.
TMEM192
-/- murine embryonic fibroblasts (MEFs) exhibited a regular morphology of endo-/lysosomes and were capable of performing autophagy and lysosomal exocytosis. Histopathological, ultrastructural and biochemical analyses of all major tissues of
TMEM192
-/- mice demonstrated normal lysosomal functions without apparent lysosomal storage. Furthermore, the abundance of the major immune cells was comparable in
TMEM192
-/- and wild type mice. Based on this, we conclude that under basal conditions in vivo the loss of
TMEM192
can be efficiently compensated by alternative pathways. Further studies will be required to decipher its molecular function.
...
PMID:Functional characterization of the lysosomal membrane protein TMEM192 in mice. 2850 66